Streetbeat News

Stock Prices

U

Unity Software shares rose following an upgrade by Morgan Stanley from Equal-Weight to Overweight.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:48 am

PCVX

Vaxcyte shares rise as the company advances VAX-31 to a Phase 3 program after positive Phase 1/2 results.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:46 am

DYN

Dyne Therapeutics shares are trading lower following the announcement of new clinical data from its Phase 1/2 DELIVER trial of DYNE-251. The trial showed unprecedented dystrophin expression and functional improvement in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:44 am

ATI

ATI's board has authorized a repurchase of up to $700 million of its common stock, supporting a multi-year share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:32 am

PRAX

Praxis Precision Medicines announced positive topline results from its Phase 2 study of Relutrigine, showing a 46% reduction in monthly motor seizures in patients with SCN2A and SCN8A developmental and epileptic encephalopathy during the double-blind period.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:32 am

SPY

VGK

A Russian missile strike in Poltava, Ukraine, resulted in 41 deaths and over 180 injuries, as reported by Ukraine's President Zelenskiy on Telegram.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:23 am

LI

NIO

TSLA

Tesla's stock is rising in premarket trading due to strong China sales in August, with a 17% increase from July. This performance aligns with domestic rivals like BYD, while Nio and Li Auto saw declines. Tesla's zero-interest financing may have contributed to the sales boost.

Portfolio Pulse from Shanthi Rexaline

September 03, 2024 | 11:20 am

BITF

Bitfarms reported a decrease in Bitcoin mining output, generating 233 BTC in August compared to 253 BTC in July.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:18 am

RDHL

Redhill Biopharma published data from a Phase 2/3 study of Opaganib in COVID-19 pneumonia, showing a 62% reduction in mortality and a 21% improvement in time to room air. The study suggests FiO2 levels as a potential biomarker for disease severity.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:14 am

IQ

SCOR

SGRP

The article highlights three oversold stocks in the communication services sector: comScore Inc (SCOR), SPAR Group Inc (SGRP), and iQIYI Inc (IQ). These stocks have RSI values below 30, indicating potential undervaluation. comScore reported disappointing Q2 results, SPAR Group showed strong sales growth, and iQIYI was downgraded by Goldman Sachs.

Portfolio Pulse from Avi Kapoor

September 03, 2024 | 11:11 am